While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body’s defenses are unable to eliminate the virus, allowing it to persist in the blood and liver.

The antiviral tenofovir disoproxil fumarate (TDF) is currently the most widely used treatment for CHB. However, long-term treatment with TDF causes a gradual decrease in kidney function and bone ...